4.6 Article

Fabrication of Size-Controllable and Arrangement-Orderly HepG2 Spheroids for Drug Screening via Decellularized Liver Matrix-Derived Micropattern Array Chips

Journal

ACS OMEGA
Volume 7, Issue 2, Pages 2364-2376

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsomega.1c06302

Keywords

-

Funding

  1. National Natural Scientific Foundations of China [82070640, 81800562]
  2. Technological Innovation Project of Chengdu New Industrial Technology Research Institute [2018-CY02-00046-GX]
  3. 1.3.5 project for disciplines of excellence, West China Hospital Sichuan University [ZYJC21014]

Ask authors/readers for more resources

By using decellularized liver matrix and micropattern array chips, this study developed a system for generating size- and arrangement-controllable HepG2 spheroids for drug screening. The decellularized liver matrix showed superior biological performance in terms of cell adhesion, proliferation, and functions compared to collagen type I and Matrigel. The optimal shape and size of the micropattern were determined by evaluating the morphology, viability, and functions of the HepG2 3D cellular aggregates. Drug screening testing demonstrated that the effect of drugs on spheroids could be directly observed using confocal microscopy to measure spheroid viability.
Three-dimensional (3D) culture via micropattern arrays to generate cellular spheroids seems a promising in vitro biomimetic system for liver tissue engineering applications, such as drug screening. Recently, organ-derived decellularized extracellular matrix emerges as arguably the most biomimetic bioink. Herein, decellularized liver matrix (DLM)-derived micropattern array chips were developed to fabricate size-controllable and arrangement-orderly HepG2 spheroids for drug screening. The porcine DLM was obtained by the removal of cellular components and then ground into powder, followed by enzymolysis. DLM as a coating substrate was compared with collagen type I (Col I) and Matrigel in terms of biological performance for enhancing cell adhesion, proliferation, and functions. Subsequently, we used poly(dimethylsiloxane) (PDMS) to adsorb DLM as the bioink to fabricate micropattern array chips. The optimal shape and size of micropattern were determined by evaluating the morphology, viability, and functions of HepG2 3D cellular aggregates. In addition, drug-susceptibility testing (paclitaxel, doxorubicin HCl, and disulfiram) was performed on this novel platform. The DLM provided the tissue-specific microenvironment that provided suitable supports for HepG2 cells, compared to Col I and Matrigel. A circular micropattern with a diameter of 100 mu m was the optimal processing parameter to rapidly fabricate large-scale, size-controllable, and arrangement-orderly HepG2 cellular aggregates with 3D spheroid's shape and high cell viability. Drug screening testing showed that the effect of a drug could be directly demonstrated on-chip by confocal microscopy measuring the viability of spheroids. We provide a novel platform for the large-scale generation of HepG2 spheroids with uniform size and arrangement, thus bringing convenience, reducing error, and increasing reproducibility for a rapid drug discovery by fluorescence quantitative analysis. This methodology may be possible to apply in advancing personalized medicine and drug discovery.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available